Alumni Capital

78 days ago

Steve O’Hara’s US death spiral predator pals find another UK victim in Beowulf

I wonder whether US death spiral vulture Alumni Capital still owns 3.1% of Optibiotix (OPTI). It has never actually issued a TR1 and the terms of its investment were incredibly vague. Now it has another victim

131 days ago

Anglesey Mining – is this the Feck You Moment Reached?

Anglesey Mining (AYM) celebrated its 41st birthday last month. It has never made a profit but has limped on with mug punters ponying up for placement after placement after sodding placement. But as is often the way, at some point, impoverished shareholders look at fat cat directors and parasitical advisers and say “feck you - we do not care if we lose everything we just want to stop funding your life of Ukrainian Young Ladies and Colombia’s finest.”

137 days ago

Tom Winnifrith Bearcast: James "Dracula" Parsons is back on this happy Welsh day

I start with another triumph my cottage burner of a son Joshua and also for Plaid Cymru in Caerphilly. What does that Senedd election mean for political betting? Then it is Anglesey Mining (AYM), Alumni Capital, Optibiotx (OPTI), Skinbiotherapeutics (SBTX), Eqteq (EQT) and Eco Buildings (ECOB).

165 days ago

Optibiotix backer Alumni Capital shows its true death spiral colours with Anglesey Mining

When he was not wasting Police Time by trying to get me arrested, Lyin’ Steve O Hara of Optibiotix (OPTI) insisted that his most recent placing was with a new US “institutional investor” and one with relevant sector expertise. I said, at the time, that Alumni Capital provided complex financial structures with fees obfuscating its actual entry price and was in many cases just a plain old death spiral provider and a rapacious one to boot. Guess what?

255 days ago

Optibiotix: where is the TR1?

I am told by folks close to Optibiotix (OPTI), not CEO Lyin’ Steve O Hara who would rather brief against me than deal with numerous corporate governance failures, that results will arrive on deadline day Monday. So the shares will not be suspended although why it takes a company with sub £1 million sales six months to get its numbers ready is a matter of shame, another corporate governance fail. Meanwhile…

276 days ago

Tom Winnifrith Bearcast: Dancing on a pinhead with PL over the Optibiotix RNS as I investigate the modus operandi of Alumni Capital

The podcast covers what it says on the tin, my desktop research late last night about Alumni should concern us all and makes that RNS look ever more pungent

277 days ago

Letter to Liam Murray at Cairn and AIM regulation Re Optibiotix fund raise

I have written to Liam “the Toke” Murray at Nomad Cairn and, in case, he is dozing on a mushroom, cc’d in AIM Regulation regarding the 23 May £500,000 raised by Optibiotix (OPTI) with what it termed a specialist “institutional investor” and what lyin’ Steve O’Hara subsequently stated was a “strategic investor,” Alumni Capital. A new RNS is needed.

279 days ago

BREAKING: Optibiotix names the US “strategic and specialist investor” and it has already been selling shares.

On Friday 23 May Optibiotix (OPTI) announced a placing with a US “specialist” investor taking £500,000 of shares at 14p. It did not name that investor but the implication was that this was a kosher long term fundamentals based investor. Even yesterday Steve O'Hara was briefing that it was a "strategic investor." Today it has updated its Rule 26 page and the ghastly truth is starting to slip out.